CIK 0001761612 · Non-accelerated filer<br>Smaller reporting company
BICYCLE THERAPEUTICS PLC
Sign in to watch- Ticker
- BCYC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 011441223261503
- Business address
- BLOCKS A & B, PORTWAY BUILDING, GRANTA PARK, GREAT ABINGTON, CAMBRIDGE, United Kingdom, CB21 6GS
- Former names
- BICYCLE THERAPEUTICS Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $64,039
- in 7 filings, $7K under 10b5-1 plans
Net −$64,039. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Lee Kevin −$27K CHIEF EXECUTIVE OFFICER sold 1% of stake
- Swanton Robert Charles −$12K Director sold 18% of stake
- Skynner Michael −$9K CHIEF SCIENTIFIC OFFICER sold 2% of stake
- Perry Jennifer Scott −$7K Chief Operating Officer sold 2% of stake
- Hannay Michael Charles Ferguson −$6K CHIEF PROD & SUPPLY CHAIN OFF sold 2% of stake
Reading 60 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-05 | Perry Jennifer Scott Chief Operating Officer | Sale 10b5-1 | −30 | $3.57 | $107 | 89,928 |
| 2026-10-05 | Perry Jennifer Scott Chief Operating Officer | Sale 10b5-1 | −326 | $3.78 | $1K | 89,602 |
| 2026-10-05 | Perry Jennifer Scott Chief Operating Officer | Sale 10b5-1 | −80 | $3.56 | $285 | 89,878 |
| 2026-10-05 | Perry Jennifer Scott Chief Operating Officer | Sale 10b5-1 | −326 | $3.78 | $1K | 89,552 |
| 2026-10-05 | Hannay Michael Charles Ferguson CHIEF PROD & SUPPLY CHAIN OFF | Sale | −242 | $3.57 | $864 | 92,561 |
| 2026-10-05 | Thompson Travis Alvin Chief Financial Officer | Sale | −79 | $3.57 | $282 | 64,449 |
| 2026-10-05 | Lee Kevin CHIEF EXECUTIVE OFFICER | Sale | −1,638 | $3.57 | $6K | 595,866 |
| 2026-10-05 | Skynner Michael CHIEF SCIENTIFIC OFFICER | Sale | −503 | $3.57 | $2K | 154,726 |
| 2026-10-02 | Perry Jennifer Scott Chief Operating Officer | Sale 10b5-1 | −1,094 | $3.47 | $4K | 89,958 |
| 2026-10-02 | Swanton Robert Charles Director | Sale | −3,431 | $3.47 | $12K | 15,782 |
| 2026-10-02 | Hannay Michael Charles Ferguson CHIEF PROD & SUPPLY CHAIN OFF | Sale | −1,572 | $3.47 | $5K | 92,803 |
| 2026-10-02 | Thompson Travis Alvin Chief Financial Officer | Sale | −893 | $3.47 | $3K | 64,528 |
| 2026-10-02 | Lee Kevin CHIEF EXECUTIVE OFFICER | Sale | −6,167 | $3.47 | $21K | 597,504 |
| 2026-10-02 | Skynner Michael CHIEF SCIENTIFIC OFFICER | Sale | −1,942 | $3.47 | $7K | 155,229 |
| 2026-07-15 | Perry Jennifer Scott Chief Operating Officer | Grant or award · Employee Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2026-07-15 | Hannay Michael Charles Ferguson CHIEF PROD & SUPPLY CHAIN OFF | Grant or award · Employee Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2026-07-15 | Thompson Travis Alvin Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2026-07-15 | Skynner Michael CHIEF SCIENTIFIC OFFICER | Grant or award · Employee Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2026-07-06 | Perry Jennifer Scott Chief Operating Officer | Sale 10b5-1 | −43 | $4.31 | $185 | 91,385 |
| 2026-07-06 | Perry Jennifer Scott Chief Operating Officer | Sale 10b5-1 | −333 | $4.34 | $1K | 91,052 |
Page 1 of 26 · 520 trades